TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02445677

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active transcutaneous electrical nerve stimulation (TENS)
Description: TENS is a technique use to relieve pain in an injured or diseased part of the body in which electrodes applied to the skin deliver intermittent stimulation to surface nerves and block the transmission of pain signals. In this research, the frequency will be set at 100 Hz, implusion duration at 60 μsec and intensity will be increase until having strong but confortable stimulations.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Simulated transcutaneous electrical nerve stimulation (TENS)
Description: A modification of the TENS connexion parameters will prevent the current from reaching the electrods (once a first sensation will be perceived).
Study: NCT00123578

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorazepam
Description: Lorazepam

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pentobarbital
Description: Pentobarbital
Study: NCT00856206

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rilonacept
Description: Rilonacept 160 mg subcutaneous injection once a week

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo subcutaneous injection once a week
Study: NCT02950987

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole Body MRI
Study: NCT03958721

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1,000 mg/m2 twice daily taken by mouth every other week

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Once daily (Monday through Friday) for six weeks
Study: NCT00931762

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panobinostat
Description: Panobinostat oral capsules
Study: NCT03931291

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APR-246
Description: APR-246 will be administered on Days 1-4, with azacitidine on Days 1-5, of every 28 day cycle. Patients may receive a maximum of 12 cycles.
Study: NCT01579175

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chewing gum
Description: Sugar Free (Extra spearment) gum given to chew every 4 hours during waking hours for 15 minutes.
Study: NCT04190394

Intervention type: OTHER
Intervention: Intermittent retraining program.
Description: Patient benefits from an intermittent retraining program for 8 weeks, with three 45-minute sessions per week.
Study: NCT02175589

Intervention type: OTHER
Group type: OTHER
Intervention: Colchicine Cessation
Description: Colchicine Cessation
Study: NCT01320085

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEK162

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEK162

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEK162
Study: NCT04478474

Intervention type: DRUG
Intervention: Ganciclovir
Description: Type of allogeneic transplant, HLA match, graft manipulation, use of ATG and/or Campath, CMV status (donor and recipient), maximal acute GVHD stage and grade, CMV viremia/disease through day +100, days received ganciclovir prophylaxis, adverse events related directly or secondary to ganciclovir prophylaxis.
Study: NCT03980106

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reciprocal Inhibition Muscle Energy Technique
Description: In this technique, the subject will be asked to contract antagonist muscles against a moderate resistant force provided by the therapist to inhibit the contraction of the agonist muscle.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reciprocal Inhibition Muscle Energy Technique
Description: In this technique, the subject will be asked to contract antagonist muscles against a moderate resistant force provided by the therapist to inhibit the contraction of the agonist muscle.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-Isometric Inhibition Muscle Energy Technique
Description: In this technique, the subject will be asked to contract agonist muscles against a moderate resistant force provided by the therapist to inhibit the contraction of the agonist muscle.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-Isometric Inhibition Muscle Energy Technique
Description: In this technique, the subject will be asked to contract agonist muscles against a moderate resistant force provided by the therapist to inhibit the contraction of the agonist muscle.
Study: NCT01819402

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pioglitazone vs Glimepiride

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Pioglitazone vs Glimepiride
Study: NCT03902197

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD19 hsCAR-T
Description: CD19 hsCAR-T will be administered by I.V. infusion
Study: NCT01934530

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Soft Tissue Grafting
Description: All patients were treated with infiltration of local anesthetic with vasoconstrictor if noted tolerable by the medical history. Surgeons were then notified if the patient was randomized to the test or control according to a blinded treatment assignment. In both groups, anesthesia was confirmed at the implant site and the palatal donor site if indicated. The recipient bed was then prepared.~Vertical incisions were made at the defect at line angles and horizontal incisions connected the two vertical releases intrasulcularly without involving the interdental papilla. The flap was reflected as a full thickness flap maintaining the integrity of the collagen attachment with de-epithelialization of papilla to allow for coronal advancement.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Soft Tissue Grafting
Description: All patients were treated with infiltration of local anesthetic with vasoconstrictor if noted tolerable by the medical history. Surgeons were then notified if the patient was randomized to the test or control according to a blinded treatment assignment. In both groups, anesthesia was confirmed at the implant site and the palatal donor site if indicated. The recipient bed was then prepared.~Vertical incisions were made at the defect at line angles and horizontal incisions connected the two vertical releases intrasulcularly without involving the interdental papilla. The flap was reflected as a full thickness flap maintaining the integrity of the collagen attachment with de-epithelialization of papilla to allow for coronal advancement.
Study: NCT03935529

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural Activation
Description: Participants will receive five sessions of Behavioural Activation. Behavioural Activation uses strategies such as activity scheduling, mastery and pleasure ratings, and graded task assignments to change a participant's perception of specific situations.~Behavioural Activation is based on the behavioural model of depression (Lewinsohn \& Shaffer, 1971). Specifically, that depression is a result of reduced positive reinforcement, particularly in social relationships. Behavioural Activation aims to reduce depressive symptoms by implementing a schedule of positive reinforcement by altering a participant's behaviour and/or their environment. As, in certain environmental contexts, behaviours that reduce depression will continue to occur through reinforcement and those that increase depression will decrease over time (Roane, Fisher, \& Carr, 2016).~Behavioural Activation has been shown to be an effective intervention for the reduction of depressed mood.
Study: NCT04497506

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wise Intervention (Self-affirmation and Incremental theory of personality)
Description: The intervention designed to promote prosocial behavior and reduce online risks is based on four general types of change strategies: (1) scientific knowledge, (2) generation of new meanings, (3) commitment through action, and (4) active reflection. It includes two components: a self-affirmation activity and an ITP intervention. The SA component includes a list of values so that they could choose the two or three most important for them. Next, they are asked to write why those selected values are the most important to them. The ITP component includes activities such as reading scientific information about social behavior and its role in people's well-being, the meaning and value of online risk behaviors through stories and videos of the experiences of other young people of their age, and self-persuasion exercises that involve an active commitment to change.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standard preventive intervention
Description: It consists of an educational intervention that provides a number of strategies to manage everyday conflicts among adolescents. This intervention teaches them new ways to manage these difficulties through different actions (relaxation, distraction, sports, etc.). Finally, they are asked to plan the strategies they will use in the future in the face of some difficulties and to recommend some guidelines for another adolescent who may be going through a similar situation.
Study: NCT03613012

Intervention type: DIAGNOSTIC_TEST
Intervention: Pain index
Description: Record the patients' EEG and extract pain index before and after pain treatments
Study: NCT00003204

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Given PO

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rituximab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT00329381

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Xolair
Description: Xolair 150-375 mg SQ every 2 or 4 weeks based on body weight and pre treatment IgE level.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xolair
Description: Xolair 150-375 mg SQ every 2 or 4 weeks based on body weight and pre treatment IgE level.
Study: NCT03051035

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KO-947
Description: Intravenous administration
Study: NCT01221883

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diazepam
Description: Single dose 10mg Diazepam tablet

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Diazepam
Description: Single dose 10mg Diazepam tablet
Study: NCT03827304

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Distraction from Burn Pain
Description: Patients wore a VR headset while undergoing a burns dressing change
Study: NCT02069301

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated Depression/Microfinance Group
Description: LIFE-DM Integrated Depression and Microfinance group, uses behavior activation and problem solving therapy skills to teach patients how to manage mood and reach livelihood goals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as Usual
Description: National Guideline for antidepressant care

Intervention type: OTHER
Group type: OTHER
Intervention: Treatment as Usual
Description: National Guideline for antidepressant care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Livelihood Support
Description: Livelihood support, including group-based loans to develop small enterprise, personal finance management education, business management skills, vocational training, and rotating-credit savings program.
Study: NCT02933125

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group psychotherapy
Description: Motivational enhancement psychotherapy (MEP) for Youths:~The participating youths have to attend one session a week for 10 weeks of a group program for relapse prevention based on motivational enhancement ideas and led by two experienced psychologists from the hospital.~Parenting skill training (PST) for Caregivers:~The PST program for the youths' caregivers also consist of 10 weekly, 120-minute sessions that were led by a senior consulting psychologist.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard supervision
Description: The standard supervision by the protection officers in Taiwan's Kaohsiung Juvenile and Family Court provide the adolescents with moral education, as well as counseling in their work or studies.
Study: NCT03510884

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab SAR236553 (REGN727)
Description: Pharmaceutical form:solution Route of administration: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab SAR236553 (REGN727)
Description: Pharmaceutical form:solution Route of administration: subcutaneous injection
Study: NCT01678079

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Encapsulated Calcium
Description: The intervention is a multi-micronutrient powder containing enteric-coated calcium carbonate, in addition to ferrous fumarate (60 mg of elemental iron) and folic acid (400 µg).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Encapsulated Calcium
Description: The intervention is a multi-micronutrient powder containing enteric-coated calcium carbonate, in addition to ferrous fumarate (60 mg of elemental iron) and folic acid (400 µg).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Encapsulated Calcium
Description: The intervention is a multi-micronutrient powder containing enteric-coated calcium carbonate, in addition to ferrous fumarate (60 mg of elemental iron) and folic acid (400 µg).

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-capsulated Calcium
Description: The comparator/control intervention is a micronutrient powder containing non-coated calcium (500, 1000 or 1500 mg elemental calcium from calcium carbonate), ferrous fumarate (60 mg of elemental iron) and folic acid (400 µg). This product will be similar in Ca dose, appearance, taste and texture to the experimental formulation but will not include the enteric-coating.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-capsulated Calcium
Description: The comparator/control intervention is a micronutrient powder containing non-coated calcium (500, 1000 or 1500 mg elemental calcium from calcium carbonate), ferrous fumarate (60 mg of elemental iron) and folic acid (400 µg). This product will be similar in Ca dose, appearance, taste and texture to the experimental formulation but will not include the enteric-coating.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Non-capsulated Calcium
Description: The comparator/control intervention is a micronutrient powder containing non-coated calcium (500, 1000 or 1500 mg elemental calcium from calcium carbonate), ferrous fumarate (60 mg of elemental iron) and folic acid (400 µg). This product will be similar in Ca dose, appearance, taste and texture to the experimental formulation but will not include the enteric-coating.
Study: NCT00367653

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin plus Chloroquine
Description: Azithromycin 1000 mg by mouth (PO) (two 500 mg tablets) once daily (QD) for 3 days(Days 0, 1, 2) plus chloroquine 600 mg base PO once daily for 3 days (Days 0, 1, 2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mefloquine
Description: Mefloquine 1250 mg PO given as a split dose (750 mg \[three 250 mg capsules\]) initial dose followed by 500 mg PO (two 250 mg capsules) given 6 to 10 hours later on Day 0
Study: NCT02795741

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cooling Bolero
Description: a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat
Study: NCT01199185

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking Cessation
Description: All participants will receive a smoking cessation intervention via the Proactive TARGIT Quit Line. Participants will receive access to the TARGIT Smoking Cessation Handbook which will be a useful tool to guide them through the quitting process and highlight the major points reviewed in all counseling sessions. As part of TARGIT all participants will receive nicotine replacement therapy (NRT).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking Cessation plus Weight Loss
Description: All participants will receive a smoking cessation intervention via the Proactive TARGIT Quit Line. Participants will receive access to the TARGIT Smoking Cessation Handbook which will be a useful tool to guide them through the quitting process and highlight the major points reviewed in all counseling sessions. As part of TARGIT all participants will receive nicotine replacement therapy (NRT). Participants in the Intervention Group will also receive a Behavioral Weight Loss/ Weight Gain Prevention Intervention delivered via interactive technology. The Intervention group will receive 16 weekly webinar sessions beginning 7 weeks after randomization via Cisco WebEx. The webinar sessions will present the behavioral weight loss/ weight gain prevention program. After the 16 weekly sessions, the webinar sessions will then be scheduled monthly for the next 6 months then quarterly thereafter for 12 months.
Study: NCT01823224

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2 capsules Oral Tylenol 2000 mg and IV salt water
Description: The participants randomized to receive the '2 capsules Oral Acetaminophen 500 mg and IV salt water repeated 4 hours after that dose to equal 2000mg. A pre-op pain score was obtained and pain scores every 15 min x 1 hour then per recovery routine and they did a 24 hour home diary to record pain scores for 24 hours post surgery. Their opioid morphine equivalent was recorded intraoperatively, recovery and at home. This was compared to the other group receiving IV acetaminophen.and the pain scores and morphine equivalents were collected the same as in the comparative group. Each group received a placebo version oral or iv accordingly.
Study: NCT04158141

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Decortication
Description: Undergo decortication

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Decortication
Description: Undergo decortication

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed Disodium
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed Disodium
Description: Given IV

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Pencil Beam Scanning
Description: Undergo PBS

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pleurectomy
Description: Undergo pleurectomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pleurectomy
Description: Undergo pleurectomy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT01823224

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV tylenol 1000mg and 2 oral capsule sugar pills
Description: IV acetaminophen 1000mg and 2 oral capsule sugar pills were given to participants that were randomized to receive the IV acetaminophen. The same collection of pain scores and morphine equivalents was completed the same as the other group.
Study: NCT01627314

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ProHema-CB
Description: Ex-vivo CXCR4 upregulated hematopoietic progenitor cells, cord blood
Study: NCT03510884

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab SAR236553 (REGN727)
Description: Pharmaceutical form:solution Route of administration: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab SAR236553 (REGN727)
Description: Pharmaceutical form:solution Route of administration: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Pharmaceutical form:tablet Route of administration: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Pharmaceutical form:tablet Route of administration: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Pharmaceutical form:tablet Route of administration: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Pharmaceutical form:tablet Route of administration: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Pharmaceutical form:Tablet Route of administration: Oral
Study: NCT01627314

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ProHema-CB
Description: Ex-vivo CXCR4 upregulated hematopoietic progenitor cells, cord blood

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Untreated CB
Description: Cord Blood
Study: NCT01635101

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Acetaminophen
Description: IV Acetaminophen given every 6 hours (q6h); 4 doses, in 24 hours
Study: NCT02646384

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ovarian tissue cryopreservation
Description: Ovarian tissue will be removed